Clinuvel Pharmaceuticals Limited has released a press release.
CLINUVEL strategic reorganisation to refocus on U.S. markets
Earlier from Clinuvel Pharmaceuticals
- SCENESSE® approved for EPP in Canada
- CLINUVEL publicly files 20-F to U.S. SEC
- CLINUVEL update on Level II ADR upgrade, Nasdaq uplist
- FDA relaxes SCENESSE postmarketing requirement

